Global Tumor Ablation Market Share Is Likely To Reach At A CAGR Value Of Around 13.59% By 2030

08-Feb-2023 | Facts and Factors

According to Facts and Factors, the global tumor ablation market size was worth around USD 1.35 billion in 2021 and is predicted to grow to around USD 4.69 billion by 2030 with a compound annual growth rate (CAGR) of roughly 13.59% between 2022 and 2030.

Tumor ablation is a medical technique used to treat cancer. It is minimally invasive and is a common treatment methodology used for the treatment of various types of cancer including liver, kidney, renal, or lung cancer. It is an important and recommended option for cancer patients who do not show any positive effect of radiotherapy or chemotherapy. Tumor ablation is being considered by many institutes as the first line of treatment in case of benign tumors in the liver or small hepatocellular carcinomas.

Browse the full “Tumor Ablation Market Size, Share, Growth Analysis Report By Application (Liver Cancer, Kidney Cancer, Lung Cancer, Breast Cancer, and Prostate Cancer), By Technology (Microwave Ablation, Radiofrequency Ablation, Irreversible Electroporation Ablation, Cryoablation, and Others), By Treatment (Surgical Ablation, Laparoscopic Ablation, and Percutaneous Ablation), and By Region - Global and Regional Industry Insights, Overview, Comprehensive Analysis, Trends, Statistical Research, Market Intelligence, Historical Data and Forecast 2022 – 2030" report at https://www.fnfresearch.com/tumor-ablation-market

Most of the ablation systems consist of a needlelike device and a generator that is used to transport energy directed to the targeted site resulting in acute cellular necrosis. The systems include the use of high-intensity focused ultrasound (HIFU), microwave (MW) laser, or radio-frequency to supply enough energy for heating the targeted tissue up to at least 60 degrees Celsius with maximum efficiency. Burning is the process of increasing cancer cell temperature so that the cancer cells die whereas freezing refers to cryoablation which requires decreasing the temperature to below -40 degrees Celsius.

The global tumor ablation market is projected to grow due to the increasing research and development in the field of tumor ablation which is further propelled by the growing number of product innovations, launches, and approvals. Tumor ablation is an effective treatment plan for various cancers, and even though they sometimes are less effective than surgery, the technique has been known to be extremely beneficial for some patients. In many cases, people who are awaiting liver transplants are also treated using tumor ablation.

The rising number of new ablation devices to remove small tumors is a leading factor for global market growth. Microwave ablation (MWA) is gaining popularity for the treatment of localized tumors in different types of organ systems. This is because microwave ablation has shown a higher performance yield as compared to other ablation techniques. In MWA, liver tumors are destroyed by the use of microwave energy since they offer a better speed of tumor destruction. With MWA, medical professionals can target numerous liver tumors simultaneously and they can also target large-sized tumors.

One of the key factors that could act as a restraining factor is the growing advancement in alternative methods of cancer treatment. Ablation therapy may not be beneficial for all cancer patients and has limited applications. Other methods like chemotherapy have wide uses in terms of types of cancer that can be treated. As research in other segments grows in the coming years, tumor ablation techniques may lose the momentum they have gained in recent times.

The growing demand for minimally invasive techniques may provide growth opportunities while the lack of infrastructure could act as a major challenge.

Segmental Analysis:

The global tumor ablation market is segmented based on application, technology, treatment, and others

Based on application, the global market segments are liver cancer, kidney cancer, lung cancer, breast cancer, and prostate cancer. The global market was dominated by the liver cancer segment in 2021 due to the growing prevalence of the condition as well as the high output efficiency obtained by using tumor ablation techniques in treating cancer cells. The most widely prevalent type of liver cancer is hepatocellular carcinoma which has origins in the main liver cells called hepatocytes. Other types of liver cancer which are less common include hepatoblastoma and intrahepatic cholangiocarcinoma. In almost 43% of the early diagnosed cases of liver cancer, the 5-year survival rate is around 35% as per Cancer.Net.

Based on technology, the global market is segmented into microwave ablation, radiofrequency ablation, irreversible electroporation ablation, cryoablation, and others. The global market registered the highest growth in the radiofrequency ablation segment in 2021 since it is one of the most common tumor ablation techniques used in the treatment of small tumors. It makes use of high-energy radio waves where the doctor inserts the probe, through the skin, of the tumor. The radiofrequency range in this method lies between 450 to 500 kHz

 Regional Analysis;

North America is projected to register the highest CAGR in the global tumor ablation market with the US leading with surging revenue during the forecast period. The regional growth is attributed to the highly advanced cancer treatment facilities present in the USA which is home to some of the best cancer treatment centers including Johns Hopkins Hospital and Abramson Cancer Center attracting more patients to the region for treatment.

Studies have proven that the cancer survival rate due to treatment in the US is better than in any other advanced country in the world and as of 2022, the University of Texas MD Anderson Cancer Center has managed to hold its title as the best institute for cancer care. Growth in Asia-Pacific is projected to be led by increasing investments in cancer research and treatment centers.

Report Scope

Competitive Analysis:

The global tumor ablation market is led by players like Boston Scientific Corporation, SonaCare Medical, Ethicon, Inc, Chongqing Haifu Medical Technology Co, Medtronic Plc, Neuwave Medical Inc, and others.

Recent Developments:

• In April 2022, the University of Alabama used NanoKnife, a new tumor ablation therapy. The NanoKnife is an image-guided, minimally invasive procedure that makes use of electric energy to destroy cancer cells
• In January 2022, a private hospital in Mumbai, India witnessed the successful treatment of a patient in the early stage of liver cancer using a microwave ablation technique

The global tumor ablation market is segmented as follows:

By Application 

• Liver Cancer
• Kidney Cancer
• Lung Cancer
• Breast Cancer
• Prostate Cancer

By Technology

• Microwave Ablation
• Radiofrequency Ablation
• Irreversible Electroporation Ablation
• Cryoablation
• Others

By Treatment

• Surgical Ablation
• Laparoscopic Ablation
• Percutaneous Ablation

By Region

• North America
  • The U.S.
  • Canada
  • Mexico
• Europe
  • France
  • The UK
  • Spain
  • Germany
  • Italy
  • Nordic Countries
    • Denmark
    • Sweden
    • Norway
  • Benelux Union
    • Belgium
    • The Netherlands
    • Luxembourg
  • Rest of Europe
• Asia Pacific
  • China
  • Japan
  • India
  • Australia
  • South Korea
  • Southeast Asia
    • Indonesia
    • Thailand
    • Malaysia
    • Singapore
    • Rest of Southeast Asia
  • Rest of Asia Pacific
• The Middle East & Africa
  • Saudi Arabia
  • UAE
  • Egypt
  • South Africa
  • Rest of the Middle East & Africa
• Latin America
  • Brazil
  • Argentina
  • Rest of Latin America

About Us:

Facts & Factors is a leading market research organization offering industry expertise and scrupulous consulting services to clients for their business development. The reports and services offered by Facts and Factors are used by prestigious academic institutions, start-ups, and companies globally to measure and understand the changing international and regional business backgrounds. Our client’s/customer’s conviction on our solutions and services has pushed us in delivering always the best. Our advanced research solutions have helped them in appropriate decision-making and guidance for strategies to expand their business.

Contact Us:
Facts & Factors
A 2108, Sargam,
Nanded City,
Sinhagad Road,
Pune 411041, India
USA: +1 (347) 690-0211
Email: [email protected]
Web: https://www.fnfresearch.com